IceCure Medical (ICCM): היקף יתרות המזומנים של החברה

The development of IceCure Medical Ltd (ICCM) relies on the expansion of ProSense systems and FDA approval, while the sale of disposable probes ensures a steady stream of income. The company's cash liquidity confirms its financial stability, where 0.01 is recorded as the baseline value. Demand for minimally invasive methods is growing, although equipment procurement remains moderately dependent on clinic capital expenditures.
פילוחי נתונים אנליטיים מרוכזים עבור icecure-medical.com (ICCM)

This indicator tracks daily account balances, enabling the identification of abnormal liquidity drains or inefficient management of excess capital. By analyzing the history of cash balance fluctuations, an investor assesses management's ability to maintain operational resilience. For IceCure Medical Ltd (ICCM), this metric is critical, as the high costs of implementing cryoablation and a chronic lack of profitability make the company dependent on its existing cash reserves.